US tariffs: Global brokerage firm Citi sees minimal impact on Indian pharma firms
Mumbai, April 1 (IANS) Global brokerage firm Citi said on Tuesday there is a low likelihood of the US imposing tariffs on Indian pharmaceuticals, despite ongoing discussions around the issue.